SY
Shenshen Yan
cond-mat.mtrl-sciBand-aware networkcancer biologyCarcinoma, Renal Cellchemokine receptor 4cisplatin-sensitivityClear cell renal cell carcinomacond-mat.dis-nncs.LGExplainable artificial intelligence
On Valency
published · living versionsW_xjmdhns4·v1 · currentpublished
Atomistic prediction of magnetic behaviour across chemistry, structure and temperature
with Ruosong Shi, Chengbing Chen, Bicheng Liu, Daye Zheng +13
1 version
Preprints & journals
6 papers in the corpus · 2017–2026Atomistic prediction of magnetic behaviour across chemistry, structure and temperature2610.24407v1 · Ruosong Shi, Chengbing Chen, Bicheng Liu et al.2026 · 0 citationsarXivon Valency
Morphological saliency prior-guided band-aware multi-modal disease diagnostic fusion network for vibrational spectroscopy.42618105 · Song, Haitao, Zhou, Xuguang, Tang, Hui et al.2026 · 0 citationsAnalytica chimica acta. 2026;1419:345896
Hierarchy-Boosted Funnel Learning for Identifying Semiconductors with Ultralow Lattice Thermal Conductivity2501.06775v2 · Mengfan Wu, Shenshen Yan, Jie Ren2025 · 10 citationsarXiv
High-Throughput Estimation of Phonon Thermal Conductivity from First-Principles Calculations of Elasticity.36351268 · Yan, Shenshen, Wang, Yi, Tao, Fang et al.2022 · 13 citationsThe journal of physical chemistry. A. 2022;126(46):8771-8780
Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).34180759 · Wang, Wenguang, Gan, Zhilu, Liu, Qiang et al.2021 · 7 citationsBioengineered. 2021;12(1):2957-2969
Directional Design of Materials Based on the Multi-Objective Optimization: A Case Study of Two-Dimensional Thermoelectric SnSe1710.05072v2 · Shenshen Yan, Yi Wang, Zhibin Gao et al.2017 · 19 citationsChin. Phys. Lett. Vol.38, No.2 027301 (2021)
Career total: 9 works. 6 are in this corpus.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.